Pfizer (NYSE: PFE) reported that its Phase III THRIVE-131 study of inclacumab, an experimental P-selectin inhibitor for ...

AstraZeneca (LSE: AZN) has launched FluMist Home, the first FDA-approved influenza vaccine program that allows self- or ...

Japan’s Mochida Pharmaceutical has announced that Lialda (mesalazine 600mg) the will be launched on September 8, 2025, as the NHI (National Health Insurance) Drug Price was listed on August 14, 2025.

Last week, PureTech Health spun out a new company, Celea Therapeutics, which will develop its pulmonary fibrosis candidate ...

Shares of New Jersey, USA-based Tonix Pharmaceuticals rose 15.5% to $59.31 in after-hours trading on Friday, after the ...

Denmark’s Novo Nordisk scored a significant regulatory win for GLP-1 drug Wegovy (semaglutide), as the US Food and Drug ...

German family-owned pharma major Boehringer Ingelheim announced that Hernexeos (zongertinib tablets) has been recommended as a preferred subsequent therapy option for the treatment of patients with ...

The US Department of Health and Human Services has reinstated the Task Force on Safer Childhood Vaccines, a panel created by ...

The Swiss government has met with senior executives from Roche (ROG: SIX) and Novartis (NOVN: VX) to discuss the outlook for ...

Costco (Nasdaq: COST) has confirmed it will not sell the abortion pill mifepristone, which is sold under the Mifeprex brand, ...

The US Food and Drug Administration (FDA) has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults ...

US pharma major Eli Lilly is raising the list price for its obesity drug Mounjaro (tirzepatide) in the UK by as much as 170%, as the pharma industry comes under pressure from US President Donald Trump ...